Mereo BioPharma Group plc

Contributing Author

Recent Articles by Mereo BioPharma Group plc

Jan-12	Mereo BioPharma Provides Corporate Update MREO +14.75% GlobeNewswire
Dec-29	Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab (UX143) in Osteogenesis Imperfecta MREO -87.65% GlobeNewswire
Nov-10	Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Highlights MREO +5.65% MREO GlobeNewswire
Aug-12	Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights MREO +9.21% GlobeNewswire
May-13	Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights MREO -7.20% GlobeNewswire